109 related articles for article (PubMed ID: 26899138)
1. Profile of Steroid Receptors and Increased Aromatase Immunoexpression in Canine Inflammatory Mammary Cancer as a Potential Therapeutic Target.
De Andrés PJ; Cáceres S; Clemente M; Pérez-Alenza MD; Illera JC; Peña L
Reprod Domest Anim; 2016 Apr; 51(2):269-75. PubMed ID: 26899138
[TBL] [Abstract][Full Text] [Related]
2. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical vascular factor expression in canine inflammatory mammary carcinoma.
Camacho L; Peña L; Gil AG; Martín-Ruiz A; Dunner S; Illera JC
Vet Pathol; 2014 Jul; 51(4):737-48. PubMed ID: 24048323
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
Millanta F; Caneschi V; Ressel L; Citi S; Poli A
J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
[TBL] [Abstract][Full Text] [Related]
5. Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.
Spoerri M; Guscetti F; Hartnack S; Boos A; Oei C; Balogh O; Nowaczyk RM; Michel E; Reichler IM; Kowalewski MP
BMC Vet Res; 2015 Sep; 11():235. PubMed ID: 26370564
[TBL] [Abstract][Full Text] [Related]
6. Steroids and receptors in canine mammary cancer.
Illera JC; Pérez-Alenza MD; Nieto A; Jiménez MA; Silvan G; Dunner S; Peña L
Steroids; 2006 Jul; 71(7):541-8. PubMed ID: 16631217
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Expression of CCR2, CSF1R and MMP9 in Canine Inflammatory Mammary Carcinomas.
Raposo TP; Beirão BC; Pires I; Prada J; Brilhante P; Argyle DJ; Queiroga FL
Anticancer Res; 2016 Apr; 36(4):1805-13. PubMed ID: 27069163
[TBL] [Abstract][Full Text] [Related]
9. Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells.
Wang J; Gildea JJ; Yue W
Oncogene; 2013 Oct; 32(44):5233-40. PubMed ID: 23178495
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba extract EGb 761-mediated inhibition of aromatase for the treatment of hormone-dependent breast cancer.
Park YJ; Ahn HY; Kim HR; Chung KH; Oh SM
Food Chem Toxicol; 2016 Jan; 87():157-65. PubMed ID: 26706698
[TBL] [Abstract][Full Text] [Related]
11. HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis.
Tekmal RR; Nair HB; Perla RP; Kirma N
J Steroid Biochem Mol Biol; 2007; 106(1-5):111-8. PubMed ID: 17604617
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of FOXP3 expression in canine mammary gland tumours.
Oh SY; Ryu HH; Yoo DY; Hwang IK; Kweon OK; Kim WH
Vet Comp Oncol; 2014 Mar; 12(1):20-8. PubMed ID: 22541038
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118.
Gao H; Zhou H; Gao Y; He L; Li W; Xu M; Feng H; Feng X; Qiu C
Vet Comp Oncol; 2022 Sep; 20(3):679-687. PubMed ID: 35429113
[TBL] [Abstract][Full Text] [Related]
14. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
Clemente M; Pérez-Alenza MD; Illera JC; Peña L
Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772
[TBL] [Abstract][Full Text] [Related]
15. Disruption in the expression and immunolocalisation of steroid receptors and steroidogenic enzymes in letrozole-induced polycystic ovaries in rat.
Zurvarra FM; Salvetti NR; Mason JI; Velazquez MM; Alfaro NS; Ortega HH
Reprod Fertil Dev; 2009; 21(7):827-39. PubMed ID: 19698287
[TBL] [Abstract][Full Text] [Related]
16. Steroid pathway and oestrone sulphate production in canine inflammatory mammary carcinoma.
Sánchez-Archidona AR; Jiménez MA; Pérez-Alenza D; Silván G; Illera JC; Peña L; Dunner S
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):93-9. PubMed ID: 17466517
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
Mainenti M; Rasotto R; Carnier P; Zappulli V
Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
[TBL] [Abstract][Full Text] [Related]
18. Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer.
Alonso-Diez A; Affolter VK; Sevane N; Dunner S; Valdivia G; Clemente M; De Andrés PJ; Illera JC; Pérez-Alenza MD; Peña L
Res Vet Sci; 2022 Dec; 152():307-313. PubMed ID: 36084372
[TBL] [Abstract][Full Text] [Related]
19. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
20. Mammary gland development in transgenic male mice expressing human P450 aromatase.
Li X; Wärri A; Mäkelä S; Ahonen T; Streng T; Santti R; Poutanen M
Endocrinology; 2002 Oct; 143(10):4074-83. PubMed ID: 12239119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]